why choose us

First received: September 16, 2022

Clinical Trial: Standardizing Treatments for Pulmonary Exacerbations - Aminoglycoside Study

Study Status: Completed

Recruit Status: RECRUITING

Condition: Cystic Fibrosis

Study Type: INTERVENTIONAL


Official Title: Standardizing Treatments for Pulmonary Exacerbations: A Platform for Evaluating Treatment Decisions to Improve Outcomes (STOP360) Aminoglycoside Study (AG Study)

Brief Summary: The purpose of this study is to look at pulmonary exacerbations in people with cystic fibrosis (CF) that need to be treated with antibiotics given through a tube inserted into a vein (intravenous or IV).A pulmonary exacerbation is a worsening of respiratory symptoms in people with CF that needs medical intervention.Both doctors and CF patients are trying to understand the best way to treat pulmonary exacerbations.This study is trying to answer the following questions about treating a pulmonary exacerbation:Do…

Read more